While soluble CD163 is not a feature of either the HScore or HLH-2004 criteria, its value as a diagnostic and prognostic biomarker in sepsis-associated HLH has been demonstrated in a different patient population [114]. This evidence concerns the gene CD163 and hemophagocytic syndrome.